Tech Company Financing Transactions
Instylla Funding Round
Instylla secured a $25.4 million Series B funding round on 10/16/2020. Backers included AMED Ventures, Ascension Ventures and Catalyst Health Ventures.
Transaction Overview
Company Name
Announced On
10/16/2020
Transaction Type
Venture Equity
Amount
$25,400,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
201 Burlington Rd.
Bedford, MA 01730
USA
Bedford, MA 01730
USA
Phone
Website
Email Address
Not Recorded
Overview
Instylla's focus is to leverage hydrogel technology to create differentiated liquid embolics for interventional radiology with a specific initial focus on interventional oncology and peripheral hemostasis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amarpreet Sawhney
President
Pat Campbell
VP - R & D
Raymond Lareau
VP - Regulatory Affairs
Brooke Mastrorio
VP - Regulatory Affairs
Amita Shah
Browse more venture capital transactions:
Prev: 10/16/2020: QCODE venture capital transaction
Next: 10/16/2020: Twentyeight Health venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs